Drug Type Small molecule drug |
Synonyms RDEA 436, RDEA436 |
Target |
Action inhibitors |
Mechanism MEK1 inhibitors(Dual specificity mitogen-activated protein kinase kinase 1 inhibitors), MEK2 inhibitors(Dual specificity mitogen-activated protein kinase kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | United States | - | |
Inflammation | Phase 1 | - | - | |
Inflammation | Phase 1 | - | - | |
Inflammation | Phase 1 | - | - | |
Neoplasms | Phase 1 | United States | - |